Health
J&J’s COVID-19 vaccine generates positive pre-clinical results – PMLiVE
Experimental vaccine begins first-in-human trial this month
An experimental vaccine candidate currently being developed by Johnson and Johnson has proved promising in early, pre-clinical studies.
The vaccine, Ad26.COV2.S, induced a robust immune response in monkeys, demonstrated by high levels of neutralising antibodies. According to J&J, this immune response successfully prevented subsequent infection and provided complete or near-complete protection from the SARS-CoV-2 virus, which causes COVID-19.
In the studies, J&J’s researchers initially…
-
Noosa News16 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News22 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Noosa News8 hours agoItalian Film Festival, Brisbane: All the Details
-
Business20 hours agoAre BHP shares are buy after its results?